During infection by human adenovirus (HAdV), the proteins encoded by the early region 1A (E1A) gene bind and appropriate components of the cellular transcriptional machinery to activate the transcription of viral early genes. Previously, we identified roles for the human Bre1 (hBre1) and hPaf1 complexes in E1A-mediated transcriptional activation of HAdV early genes. Here we show that E1A binds hBre1 directly and that this complex targets the hPaf1 complex via the Rtf1 subunit. Depletion of hPaf1 reduces E1A-dependent activation of transcription from the E2e, E3, and E4 viral transcription units, and this does not result from a reduced ability of RNA polymerase II to be recruited to the promoter-proximal regions of these genes. In contrast, depletion of hPaf1 reduces the occupancy of RNA polymerase II across these transcription units. This is accompanied by reductions in the level of H3K36 trimethylation, a posttranslational histone modification associated with efficient transcriptional elongation, and the number of full-length transcripts from these genes. Together, these results indicate that E1A uses hBre1 to recruit the hPaf1 complex in order to optimally activate viral early transcription by enhancing transcriptional elongation.
V
iruses are obligately parasitic organisms that require host cell machinery for the infectious cycle. Human adenovirus (HAdV) usurps and reorganizes the transcriptional machinery of the infected cell for several functions, including the transcription of viral genes. To do this, HAdV produces the immediate early gene E1A (early region 1A). The transcript is alternatively spliced into 5 mRNAs, of which the 13S and 12S mRNAs predominate at early times. These encode 289-and 243-residue proteins, respectively. Based on amino acid similarity between E1As from various HAdV types, the E1A protein can be subdivided into 4 regions of high conservation, deemed conserved regions 1 to 4 (CR1 to CR4) (1, 2) . E1A has no enzymatic or specific DNA binding capabilities; instead, this viral protein modulates cellular functions via specific protein interactions with members of target complexes. These interactions often occur via linear interaction motifs, which make up the vast majority of the conserved regions of E1A. Although the largest E1A isoform in HAdV 5 has only 289 residues, it is able to interact with more than 50 cellular proteins (2, 3) . Through these interactions, E1A is able to bind to more than 17,000 human genomic promoters, resulting in cell cycle progression, dedifferentiation, and inhibition of the interferon response (3) (4) (5) . As well as modulating cellular transcription, E1A is required for the transcription of the HAdV early genes (6) (7) (8) (9) . HAdV early genes are activated through two regions of the E1A protein: CR3 and the N-terminal region, which includes CR1. Studies of transcriptional activation of HAdV early genes have revealed a cooperative effort by CR3 and the N terminus of E1A to modify the HAdV chromatin with activation marks such as H3K4 and H3K79 trimethylation, as well as to recruit transcriptional activation complexes (8, 10) . However, transcriptional regulation is a complex process involving multiple events, including initiation, elongation, and termination (11, 12) . Recent studies have shown important ratelimiting steps aside from transcriptional initiation that control mRNA production (13, 14) . Little work has been done to understand the role of transcriptional elongation in HAdV E1A-dependent transcriptional processes. A recent study (15) has suggested that CR3, through recruitment of the mediator complex and CDK9, optimizes transcriptional elongation at viral early genes. However, that work primarily demonstrated decreased transcriptional initiation when these components were depleted.
Previously, we have shown that E1A interacts with human Bre1 (hBre1), an E3 ubiquitin ligase involved in the monoubiquitination of H2B (H2B-ub) (5) . E1A binds hBre1, blocking an interaction with Ube2b, the E2 ubiquitin conjugase, thereby antagonizing the ability of hBre1 to monoubiquitinate H2B. This removes a necessary activation signal for the expression of interferon-stimulated genes and thus blocks the interferon response during infection (5). Further, E1A recruits hBre1 to HAdV early genes, whereby hBre1 is converted from an E3 ligase to a scaffold for the recruitment of the hPaf1 complex. By recruiting hPaf1 to viral early genes, the N terminus participates in E1A-dependent transcriptional activation (6). Here we have studied the role of hPaf1 in E1A-dependent transcriptional activation of HAdV early genes by examining transcriptional initiation and elongation. We have found that hPaf1 functions primarily to increase transcript elongation rather than increasing transcriptional initiation of multiple E1A-responsive early viral genes.
MATERIALS AND METHODS
Cell lines. Human adenocarcinoma A549 cells were grown at 37°C under 5% CO 2 in Dulbecco's modified Eagle medium (DMEM) (MultiCell) supplemented with 10% fetal bovine serum (Gibco).
qRT-PCR of RNA. Total RNA was prepared by TRIzol extraction from flash-frozen cells (Invitrogen). A total of 1 g of RNA was reverse transcribed into cDNA by random priming using the OneStep RT-PCR kit (Qiagen) according to the manufacturers' instructions. cDNA was quantified using SYBR Green Supermix for quantitative real-time PCR (qRT-PCR) (MyiQ; Bio-Rad) with oligonucleotide sequences that specifically recognize the indicated target. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a control for total cDNA. Controls without reverse transcriptase were carried out for each RNA sample alongside the cDNA control. Results were normalized to those for GAPDH and the uninfected sample. The oligonucleotide sequences are available upon request.
RNA interference (RNAi). hPaf1 was downregulated using Silencer Select small interfering RNA (siRNA) (Ambion). siRNA was delivered to cells via transfection with SiLentFect (Bio-Rad) according to the manufacturer's instructions 3 h after the seeding of cells. Cells were infected 48 h later. A scrambled siRNA was used as a control.
Virus infection of cells. Cells were infected with human adenovirus 5 (HAdV5) expressing wild-type (WT) E1A (dl309) or an HAdV containing a deletion of E1A (⌬E1A) (dl312). HAdV was used at a multiplicity of infection (MOI) of 5 PFU/cell. Cell cultures were infected at 50% confluence and were left for 16 h. The frequency of virus infection under these conditions, using viruses expressing green fluorescent protein (GFP), was found to be near 100% by fluorescence microscopy. Subconfluent cells were collected for further experimentation.
Western blotting and coimmunoprecipitation. Cells were lysed with NP-40 lysis buffer (150 mM NaCl, 50 mM Tris-HCl [pH 7.5], 0.1% NP-40), and protein concentrations were determined with the Bio-Rad protein assay reagent by using bovine serum albumin (BSA) as a standard. A protein lysate (0.5 mg) was immunoprecipitated with an anti-E1A specific mouse monoclonal antibody at 4°C for 4 h. Twenty-five micrograms of protein was kept as 5% input, except as noted in the figure legends for individual blots. After 3 washes in NP-40 lysis buffer, complexes were boiled in 25 l of sample buffer for 5 min. Proteins were separated on NuPage 4-to 12% Bis-Tris gradient gels (Invitrogen) and were transferred to nitrocellulose membranes (Amersham). Membranes were blocked in Tris-buffered saline (TBS) with 0.1% Tween 20 and 5% skim milk or BSA and were blotted with the primary antibodies indicated in the "Antibodies" section below overnight at 4°C. Horseradish peroxidase-conjugated secondary antibodies were detected using an ECL Plus Western blotting detection system (Amersham).
ChIP. Approximately 10 7 cells per sample were cross-linked with 1% formaldehyde at room temperature for 10 min. Cells were washed twice with ice-cold phosphate-buffered saline (PBS) and were harvested. Cell pellets were lysed in 1 ml of cell lysis buffer (50 mM Tris-HCl [pH 8.1], 10 mM EDTA, 1% SDS, and a protease inhibitor cocktail [Sigma]) on ice for 10 min. Lysates were sonicated in an ultrasonic Bioruptor bath (XL-2006; Diagenode) to yield DNA fragments in sizes ranging from 200 to 500 bp. Samples were then centrifuged at 10,000 ϫ g for 10 min. One milligram of protein was used for chromatin immunoprecipitation (ChIP), and 50 g of this was kept as 5% input. Supernatants were then diluted 10-fold in dilution buffer (20 mM Tris-HCl [pH 8.1], 1% Triton X-100, 2 mM EDTA, 150 mM NaCl, and protease inhibitors) and were precleared with 50 l of ChIP protein A-Sepharose (a 50% slurry of protein A-Sepharose containing 2.5 g of salmon sperm DNA and BSA/ml) for 50 min at 4°C.
Immunoprecipitations were performed overnight at 4°C using 5 g of the indicated antibody. The next morning, 50 l of ChIP protein A-Sepharose was incubated with each sample for 2 h. Beads were then washed once each with 500 l of wash buffer I (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl [pH 8.1], 150 mM NaCl), wash buffer II (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl [pH 8.1], 500 mM NaCl), and wash buffer III (0.25 M LiCl, 1% NP-40, 1% sodium deoxycholate, 1 mM EDTA, 10 mM Tris-HCl [pH 8.0]) and were then washed twice with Tris-EDTA buffer. Immunocomplexes were extracted twice with 150 l of elution buffer (1% SDS, 0.1 M NaHCO 3 ). For sequential ChIP (ChIPreChIP), samples were then rediluted 10ϫ with dilution buffer, and immunoprecipitation was repeated with a second antibody as indicated. After final elution, 12 l of 5 M NaCl was added to the 300-l pooled eluates, and the mixture was incubated at 65°C overnight to de-cross-link the complexes. DNA was then purified using Qiagen PCR purification spin columns. qRT-PCR using SYBR green was performed as per the manufacturers' directions. Briefly, each 15-l reaction mixture contained 80 nM oligonucleotides and 0.5 l of ChIP DNA.
Baculovirus protein expression. A baculovirus was made in Sf21 insect cells using the FASTbac1 recombination system. Sf9 cells were then infected at an MOI of 10 and were harvested 60 h postinfection. Cells were lysed in 20 mM Tris-HCl (pH 7.9), 150 mM KCl, 0.2 mM EDTA, 20% glycerol, 0.1% NP-40, 0.5 mg/ml BSA, and 0.5 mM phenylmethylsulfonyl fluoride (PMSF), and 50-g aliquots of each lysate, which included the indicated exogenous protein, were added to each immunoprecipitation mixture. The volume of protein was made equal to the volume of the extract prepared from uninfected Sf9 cells. Immunoprecipitations were then performed overnight at 4°C with the indicated antibody. Beadbound complexes were then washed 8 times in the same buffer before Western blot analysis.
Production of His-tagged E1A. Escherichia coli BL21 was transformed with pET-28a expressing 13S E1A (289R) with a C-terminal His tag. Bacteria were grown overnight at 16°C and were then lysed via sonication in 50 mM Tris-HCl (pH 7.5), 500 mM NaCl, and 5% glycerol. The lysate was spun down, and His-tagged E1A was purified with nickel resin.
Antibodies. The antibodies used in this study include the rabbit polyclonal antibodies against mouse IgG (M-7023; Sigma), actin (A2066; Sigma), GFP (lot 632592; Clontech), hPaf1 (A300-173A; Bethyl Laboratories), histone H3 trimethylated on lysine 36 (H3K36me3) (ab9050; Abcam), and RNA polymerase II (RNA pol II) (ab26721; Abcam), the mouse monoclonal antibody hBre1.RNF20 (R8904; Sigma), and a mouse monoclonal antibody against E1A (M73), prepared in-house. In addition, P. Blanchette and P. Branton kindly provided mouse monoclonal antibodies against E4orf6 (4C4) and DNA binding protein (DBP), as well as the anti-E1B rat monoclonal antibody 2A6.
Statistical analysis. All numerical values represent means Ϯ standard errors of the means (SEM). Each experiment was conducted in three replicates, and a representative replicate is shown for each blot. The statistical significance of the differences was calculated using one way analysis of variance (ANOVA) and a Holm-Sidak post hoc comparison to all other treatments in the experiment.
RESULTS
hPaf1 interacts with E1A. Previously, hPaf1 was shown to be recruited to HAdV early genes by hBre1 and E1A (6) . We first confirmed the ability of E1A to interact physically with hPaf1 via coimmunoprecipitation. A549 cells were infected with HAdV expressing either wild-type (WT) E1A or mutants with mutations in the N-terminal region of E1A at a multiplicity of infection (MOI) of 5. Cells were collected after 20 h. Lysates from infected cells were immunoprecipitated using an E1A-specific antibody, and the presence of hPaf1 was demonstrated by immunoblotting. hPaf1 was found to coprecipitate with E1A ( Fig. 1) , and this asso-ciation required E1A residues 4 to 25, the same residues that are required for binding to hBre1 (Fig. 1) (5) .
E1A binds hBre1 using the same region required for interaction with Ube2b. Previous work has mapped the interaction of hBre1 with Ube2b to residues 280 to 381 on hBre1 (16) . Since E1A blocks the interaction between hBre1 and Ube2b, we speculated that E1A competes with Ube2b for the same hBre1 binding surface. To test this, we purified recombinant hBre1 and C-terminal deletion mutants of hBre1 as glutathione S-transferase (GST) fusions, and we performed GST pulldown with 10 g of each hBre1 fragment and 5 g of purified C-terminally His tagged 13S E1A. The results of these experiments, performed using purified recombinant proteins, confirm that E1A can interact directly with hBre1. In addition, residues 280 to 381 of hBre1 were necessary for interaction with E1A (Fig. 2A) ; this is the same region that was reported to be required for interaction with Ube2b (16) .
E1A binds to the Rtf1 component of the hPaf1 complex, and this interaction requires hBre1. Our previous work showed that recruitment of the hPaf1 complex to HAdV genes required hBre1 (6) . The hPaf1 complex comprises 6 subunits: Cdc73, Ctr9, Leo1, hPaf1, Rtf1, and Ski8 (17) (18) (19) (20) . Previous work has shown that hBre1 binds to the hPaf1 complex (16) . Similarly, Rtf1 has been shown to be solely required for the activity of the hBre1 complex (21) . However, it is not clear which of these components serves to bridge hPaf1 to hBre1 in the presence of E1A. To define the component of the hPaf1 complex that is targeted by E1A through hBre1, we used a recombinant baculovirus to individually express FLAG-tagged hPaf1 components in Sf21 insect cells. After infection, complete lysates were mixed with extracts from cells expressing recombinant hBre1 and E1A in order to determine which component of the hPaf1 complex associates with E1A via hBre1. In these coimmunoprecipitation experiments, hPaf1 components were precipitated with FLAG agarose, and Western blotting was performed to detect the presence of coprecipitating E1A. Only the Rtf1 component of the hPaf1 complex was able to coprecipitate E1A, and this coprecipitation required hBre1 (Fig. 2B) . To confirm that hBre1 was necessary for this interaction, the hPaf1 complex and E1A were coexpressed with or without hBre1. As expected, E1A was unable to coprecipitate the hPaf1 complex in the absence of hBre1 (Fig. 2C) . Furthermore, in experiments using extracts containing all members of the hPaf1 complex (Fig. 2D) , Rtf1 was essential for the interaction of E1A with the hPaf1 complex (Fig. 2C) . These experiments establish that the Rtf1 component of the hPaf1 complex is necessary and sufficient for interaction with E1A via hBre1.
hPaf1 knockdown results in a decreased frequency of fulllength viral transcripts. The N terminus of E1A adapts the cellular ubiquitin ligase hBre1 to recruit hPaf1 to the viral genome, and this is required for efficient transcription of the viral E2, E3, and E4 genes but not for that of the E1A or E1B gene (6) . However, the role that the hPaf1 complex plays in enhancing viral transcription has not been established. To determine how the hPaf1 complex potentiates E1A-dependent activation of Rtf1 is sufficient to bridge hBre1 and E1A with the hPaf1 complex. Sf21 insect cells were infected with baculoviruses expressing the indicated FLAG-tagged hPaf1 complex components, E1A, or hBre1. Portions equivalent to 0.05 mg of lysates of cells infected with baculoviruses expressing both hBre1 and E1A were then mixed with 0.05 mg of a cell lysate expressing an hPaf1 complex component as indicated, and immunoprecipitation for hPaf1 complex components was performed with a FLAG-specific antibody. Western blotting was then performed using an anti-E1A antibody (M73). (C) Rtf1 is necessary to bridge hBre1 and E1A with the hPaf1 complex. Specific proteins were produced in Sf21 insect cells and were combined as described above. Immunoprecipitation was performed with an anti-E1A antibody (M73), and Western blotting was performed with an hPaf1-specific antibody, to determine whether the hPaf1 complex was coprecipitated. (D) Expression of hBre1, E1A, and hPaf1 components. Extracts from Sf21 cells infected with recombinant baculoviruses were subjected to Western blotting to confirm the expression of the indicated proteins. The star indicates the position of hPaf1. viral early gene expression, human A549 lung epithelial cells were treated with a control (Ctrl) siRNA or with siRNA specific to hPaf1 and were then infected with either WT HAdV or ⌬E1A HAdV at an MOI of 5. cDNA was prepared from cells collected 20 h postinfection. The expression of a panel of HAdV early genes known to be activated by E1A was determined by quantitative real-time PCR using multiple primer sets located at the 5= or 3= end of each viral early transcription unit. Using this approach, no differences in the level of RNA corresponding to the 5= end of each gene were noted when cells were treated with hPaf1 siRNA (Fig. 3) . This suggests that hPaf1 does not play a significant role in the initiation stages of transcription for any of the E1A-responsive viral early genes. Similarly, no change in the level of E1A or E1B RNA was detected using primer sets located at the 3= ends of their respective transcription units (Fig. 3A) . In contrast, qRT-PCR analysis revealed significant reductions in the intensities of the transcript signals corresponding to the 3= ends of the E2A (Fig. 3B), E3 (Fig. 3C) , and E4 (Fig. 3D) genes. Not surprisingly, reductions in transcription at the 3= ends of genes correlated with decreased protein production. Specifically, reduced levels of the E2e DNA binding protein (DBP) and the E4orf6 protein were detected by Western blotting, whereas no differences in E1A or E1B protein production were seen (Fig. 4) . These results suggested that the hPaf1 complex is not required for E1A-dependent transcriptional initiation. Instead, these data suggest that hPaf1 is required for efficient elongation of the E2e, E3. and E4 genes. This agrees with our previous work showing that transcription of E2e, E3, and E4 was substantially reduced by hPaf1 knockdown (6) . hPaf1 knockdown reduces RNA pol II occupancy at the 3= ends of the HAdV E2e, E3, and E4 genes. The experiments described above suggested that hPaf1 enhances transcriptional elongation for some of the early transcripts but does not play a role in transcriptional initiation. Reduced elongation should be reflected in lower RNA pol II occupancy at the 3= end of the transcribed region than at the 5= end. In contrast, decreased transcriptional initiation would result in decreased polymerase occupancy across the entire transcribed region. We measured RNA pol II occupancy across each HAdV early gene by chromatin immunoprecipitation (ChIP) (22, 23) . A549 cells were infected with WT HAdV or an HAdV containing a deletion of E1A (⌬E1A) at an MOI of 5. Cells were treated with control siRNA or siRNA specific for hPaf1. ChIP was then performed using an antibody control or an RNA pol II-specific antibody. For each transcription unit, the occupancy of RNA pol II was greatly reduced in the absence of E1A (Fig. 5) . Interestingly, the occupancy of RNA pol II was reduced at the 3= ends of the E2e, E3, and E4 transcription units when hPaf1 was depleted by siRNA. However, little or no reduction was observed at the 5= ends of these transcription units after hPaf1 knockdown (Fig.  5B, C, and D) . In contrast, hPaf1 knockdown had no effect on RNA pol II occupancy at either the 5= or 3= ends of the E1A and E1B transcription units, which do not require hPaf1 for efficient transcription (Fig. 5A) . These data suggest that hPaf1 knockdown caused elongation defects in the E2e, E3, and E4 transcription units, which could have resulted from inefficient elongation, transcriptional stalling, or premature termination.
Knockdown of hPaf1 results in a concomitant decrease in E1A occupancy at the 3= ends of the E2A, E3, and E4 transcription units. Previous work has suggested that E1A is associated with the elongating RNA polymerase on at least some of the early transcription units (24) . We assessed the occupancy of E1A across each of the early transcription units by ChIP and determined if this was influenced by the presence or absence of hPaf1 (Fig. 6 ). E1A was found to associate with all HAdV transcription units, at both the 5= and 3= ends (Fig. 6) . Interestingly, E1A showed reduced occupancy at the 3= ends of the E2A, E3, and E4 transcription units, but not the E1A and E1B transcription units, when hPaf1 was knocked down (Fig. 6B, C, and D) . These data mirror the results obtained by hPaf1 knockdown for both RNA pol II occupancy and full-length transcript production ( Fig. 3 and 4) . The results suggest that E1A not only is associated with transcriptional initiation at the 5= ends of early genes but also is likely associated with the elongating polymerase across the entire length of each of these transcription units.
Knockdown of hPaf1 results in a decrease in H3K36 trimethylation, an elongation-specific chromatin mark, at the 3= ends of the E2A, E3, and E4 transcription units. Trimethylation of H3 at lysine 36 (H3K36me3) is a posttranslational modification of histone associated with hPaf1-directed transcriptional elongation (25) (26) (27) (28) . We assessed the effects of E1A and hPaf1 on H3K36me3 across the HAdV early transcription units by ChIP assays similar to those described above. Although this elongationspecific chromatin mark was present across each of the early transcription units, it was least abundant on the E1A and E1B genes (Fig. 7) , which are the least influenced by hPaf1 (Fig. 3, 4 , 5, and 6) (6). hPaf1 knockdown reduced the frequency of H3K36me3 at the 3= ends of the E2e, E3, and E4 transcription units, but not the E1A and E1B transcription units. These results indicate that the recruitment of hPaf1 to these transcription units by E1A is critical for creating this histone modification, which is considered to be important for efficient transcriptional elongation.
Knockdown of hBre1 results in similar decreases in RNA pol II, E1A, and H3K36me3 at the 3= ends of the E2A, E3, and E4 transcription units. Given that hPaf1 recruitment depends on hBre1, we knocked down hBre1 with specific siRNA and looked for changes in the occupancy of RNA pol II, E1A, and H3K36me3 at the 3= ends of the E2A, E3, and E4 transcription units. ChIP analyses detected similar decreases in the association of RNA pol II, E1A, and H3K36me3 at the 3= ends of the hPaf1-affected genes, suggesting that hBre1 and hPaf1 are similarly required for efficient elongation (Fig. 8) .
DISCUSSION
The interaction of HAdV E1A with hBre1 serves two important purposes during infection. First, E1A disrupts the hBre1 complex, thereby blocking its catalytic ability to monoubiquitinate H2B. Monoubiquitination is a mark of inducible genes that are highly transcribed, and this posttranslational histone modification is required for interferon-dependent induction of gene transcription. In this way, the interaction of E1A with hBre1 represses the cellular interferon response, which is a key antiviral defense system. Second, hBre1 is recruited by E1A to the viral genome, where it serves as a scaffold for the recruitment of hPaf1. Through hBre1, hPaf1 participates in the E1A-dependent activation of transcription from the E2e, E3, and E4 genes. However, how hPaf1 functions to potentiate E1A-dependent activation of transcription from these loci remained an open question.
In this study, we further characterized the interaction of E1A with hBre1 and the hPaf1 complex and investigated how this interaction contributes to E1A-dependent transcriptional activation of early gene expression. We demonstrated that E1A and hBre1 interact directly (Fig. 1) and defined the interaction surface on hBre1 necessary for the binding of E1A as lying between residues 280 and 381 ( Fig. 2A) . The same region of hBre1 has been identified as the interaction surface for Ube2b, providing further support for a model in which E1A competes with Ube2b for interac- tion with hBre1 (16) . Using insect cell extracts programmed with the various components of the hPaf1 complex, we also confirmed that the interaction of hPaf1 with E1A requires hBre1 and determined that the Rtf1 component of the hPaf1 complex is the critical component that bridges the hPaf1 complex to E1A and hBre1 (Fig.  2B to D) . Although this finding differs from previous data that showed a direct interaction between hBre1 and hPaf1 (16), E1A may rewire interactions to require Rtf1 for hPaf1 recruitment. Interestingly, Rtf1 has been shown to be singularly required for the localization of the Bre1 complex and the monoubiquitination of H2B in yeast (21) . Thus, Rtf1 is required for Bre1 complex activity but may also play a role in targeting the complex to specific loci and in the interaction with Bre1.
Our results provide strong evidence that the hPaf1 complex plays an important role in enhancing the expression of the viral E2e, E3, and E4 genes by promoting transcriptional elongation. Specifically, depletion of hPaf1 by siRNA reduces the density of RNA pol II at the 3= ends, but not the 5= ends, of these genes, as detected by ChIP (Fig. 5) . There was also a corresponding reduction in the density of H3K36me3, an elongation-specific chromatin mark, across these transcriptional units when hPaf1 was depleted (Fig. 7) . Functionally, in the absence of hPaf1, there is a significant decrease in the detection of the 3= but not the 5= ends of mRNAs from these transcription units, indicating shortened transcripts (Fig. 3A to D) caused by reduced elongation, which resulted in decreased protein expression (Fig. 4) . Overall, these data indicate RNA pol II pausing and/or premature termination in the absence of the hPaf1 complex, which would result in a reduced pool of translatable mRNA species from these viral early genes. hBre1 knockdown showed similar results (Fig. 8) , further suggesting that hBre1 is involved in the recruitment of hPaf1 and therefore in hPaf1 activity on viral chromatin. Taken together, these results suggest that the recruitment of hPaf1 by E1A to a subset of HAdV early genes via hBre1 is required for RNA pol II to effectively traverse the transcribed regions of the viral genes.
Initial work on the adenovirus genome showed transcriptiondependent chromatinization of the adenoviral genome (29) . Since this discovery, the importance of the chromatinization of the viral genome in DNA damage (30) and transcription control (31, 32) has become increasingly apparent. Previous work from our lab has further shown regulatory roles for chromatin modifications within the promoter regions of the viral genome (6) . The increasing number of similarities with control of transcription by mammalian chromatin suggests that additional chromatin-dependent regulatory mechanisms, such as the use of histone variants, may also be used to control viral transcription. This has already been seen for other viruses, such as herpes simplex virus 1 (33) . Considering this, it seems very likely that other transcriptional regulators that are recruited to the viral genome may play a role in the regulation of the viral chromatin state through histone modification. Indeed, the p300/CBP and GCN5 acetyltransferases interact with E1A and have been shown to control viral gene transcription (9, 10) . How these cellular regulatory proteins function mechanistically to influence transcription from the viral genome has not been investigated from the perspective of chromatin modification. Future studies in this area may reveal that they function similarly to their well-established histone acetylation activity on cellular chromatin.
E1A has been a paradigm of viral transcriptional activation for decades. It contains two independent activation domains, which are localized to the N terminus and the more centrally located CR3. The recruitment of E1A to target genes via interactions with DNA-bound factors in promoter-proximal locations initiates the nucleation of a potent transcriptional regulatory complex. These interactions include factors typically considered to be involved in transcriptional initiation via CR3, such as the Mediator complex and TATA-binding protein (TBP). However, in addition to being localized to viral promoters, E1A has been suggested to coassociate with the elongating polymerase complex (24) . We confirmed that E1A is present at both the 5= and 3= ends of the early viral transcription units (Fig. 6) . The association of E1A with the elongating polymerase appears to serve as a mechanism for efficiently tethering the hPaf1 complex and its associated partners responsible for histone modifications, such as H3K36me3, to the elongation complex. This process requires the interaction of E1A with hBre1, which subsequently recruits the hPaf1 complex. In the absence of these N-terminally mediated interactions, E1A-induced expression from multiple early transcription units is greatly reduced. Taking our findings together, the N-terminal and CR3 H3K36me3 of chromatin at the 3= ends of the viral E2A, E3, and E4 transcription units. A549 cells were treated with Ctrl or hBre1 siRNA for 48 h. Cells were then infected with the WT or ⌬E1A virus for 16 h. ChIP analyses were performed to determine the frequency of occupancy by RNA pol II (A), E1A (B), and H3K36me3 (C) at the 5= and 3= ends of HAdV genes E2A, E3, and E4. Primer pairs are the same as those shown in Fig. 3. portions of E1A appear to work together to maximize early viral transcription by stimulating both efficient elongation and efficient initiation.
